JSM Activity #180This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions. To View the Program: You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time. |
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2003 Program page |
Legend: = Applied Session,
= Theme Session,
= Presenter Hotels: H = Hilton San Francisco, R = Reniassance Parc Hotel 55, N = Nikko San Francisco |
||
180 | Mon, 8/4/03, 2:00 PM - 3:50 PM | H-Continental Ballroom 9 |
Methods for Survival Data I - Contributed - Papers | ||
Biopharmaceutical Section | ||
Chair(s): Sarah J. Kogut, Medtronic Neurological | ||
2:05 PM | Optimal Estimator for the Survival Distribution for Treatment Policies in Two-Stage Randomization Designs in Clinical Trials — Abdus Shakoor F. Wahed, North Carolina State University; Anastasios A. Tsiatis, North Carolina State University | |
2:20 PM | Weighted Estimators for Proportional Hazards Model with Missing Covariates — Lihong Qi, University of Washington; C. Y. Wang, Fred Hutchinson Cancer Research Center; Ross L. Prentice, Fred Hutchinson Cancer Research Center | |
2:35 PM | Cox Proportional Hazards Analyses with Small Centers — Fraser B. Smith, Food and Drug Administration; Hong Laura Lu, Food and Drug Administration | |
2:50 PM | Impact of Misspecification in Cox Regression Models — Akiko Okamoto, Johnson & Johnson Pharmaceutical Research and Development, LLC; Yi-Wen Ma, Johnson & Johnson Pharmaceutical Research and Development, LLC; Surya P. Mohanty, Johnson & Johnson Pharmaceutical Research and Development, LLC | |
3:05 PM | Small-Sample Behavior of Robust Score and Wald Tests Arising from a Misspecifed Cox Proportional Hazards Model — Eric S. Leifer, National Heart, Lung & Blood Institute; Gregory DiRienzo, Harvard School of Public Health; Stephen W. Lagakos, Harvard School of Public Health; Eric V. Slud, University of Maryland; David Hoberman, Food and Drug Administration | |
3:20 PM | A Comparison Between Andersen-Gill and Lin-Wei-Yang-Ying Model for Hypoglycemia Data — Boll Wu, Aventis Pharmaceuticals, Inc.; Robert Costello, Aventis Pharmaceuticals, Inc.; Lu Tian, Harvard School of Public Health | |
3:35 PM | Generalized Log-Rank Test for Interval-Censored Failure Time Data — Qiang Zhao, University of Missouri; Jianguo (Tony) Sun, University of Missouri | |
JSM 2003
For information, contact meetings@amstat.org
or phone (703) 684-1221. If you have questions about the Continuing Education program,
please contact the Education Department. |